WeVote
Log In

Bill

Bill

HB 1108

RELATING TO MANUFACTURED HEMP PRODUCTS.

2026 Regular Session Introduced by Nadine Nakamura

Hawaii bill HB 1108 establishes regulatory standards for manufactured hemp products to ensure consumer safety and market transparency through testing and labeling requirements.

Carried over to 2026 Regular Session.
#doh #definition #manufacturedhempproducts
0
WeVote Research Nonpartisan
Bill Summary · HB 1108

Legislative bill overview

HB 1108 relates to the regulation and oversight of manufactured hemp products in Hawaii. The bill was introduced in January 2025 and has been referred to the Health (HLT) and Consumer Protection (CPC) committees for consideration. As of December 2025, the bill was carried over to the 2026 legislative session, indicating it did not advance to a vote in the current session.

Why is this important

Hemp product regulation affects consumer safety, product labeling standards, and the emerging hemp/CBD market in Hawaii. Clear regulatory frameworks can protect consumers from mislabeled or contaminated products while providing clarity for legitimate businesses operating in this sector.

Potential points of contention

  • Scope of regulation - Whether the bill regulates all hemp-derived products (including CBD, Delta-8, Delta-10) or only specific categories
  • Testing and labeling requirements - Balancing consumer protection with compliance costs that may burden small businesses
  • Local vs. state authority - Potential conflicts over whether counties or the state legislature should set manufacturing and sales standards for hemp products

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.